Enveric Biosciences, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ENVB Nasdaq 2834 www.enveric.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Enveric Biosciences, Inc.

Enveric Biosciences announces issuance of U.S. patent - Dec 30th, 2025 6:10 am
Enveric Biosciences Announces Patent Issuance - Dec 29th, 2025 6:00 am
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Dec 15th, 2025 6:03 am
Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds - Dec 12th, 2025 2:46 pm
Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds - Dec 11th, 2025 11:43 am
Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug Candidates - Dec 9th, 2025 6:00 am
Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During "J.P. Morgan Week 2026" - Dec 4th, 2025 6:00 am
Enveric Biosciences Receives Fourth Notice of Allowance for EVM401 Series of Drug Candidates - Nov 26th, 2025 6:00 am
Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results - Nov 14th, 2025 2:05 pm
Enveric Biosciences Announces Reverse Stock Split - Oct 23rd, 2025 6:00 am
Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance - Oct 16th, 2025 6:30 am
AbbVie's Bretisilocin Hit With Enveric IP Claim - Oct 15th, 2025 12:48 pm
Enveric Biosciences hires Fish & Richardson to defend patent tied to AbbVie deal - Oct 15th, 2025 6:30 am
Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal - Oct 15th, 2025 6:00 am
Enveric Biosciences to Explore Digital Asset Treasury Opportunities - Oct 14th, 2025 7:00 am
Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials - Oct 2nd, 2025 6:45 am
Enveric Biosciences Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds - Sep 18th, 2025 2:30 pm
Enveric Biosciences Announces Exercise of Warrants for $2.2 Million Gross Proceeds - Sep 17th, 2025 7:24 am
Enveric Biosciences Announces Publication of Two Peer-Reviewed Articles Highlighting Novel Bioproduction Methods for Neuropsychiatric Drug Discovery - Sep 17th, 2025 6:00 am
Enveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND Submission - Sep 16th, 2025 6:45 am